We also observed that inhibitor of differentiation 3 (ID3), which belongs to the helix-loop-helix (HLH) TF superfamily, is upregulated in the tumors of melanoma patients after their treatment with a BRAF inhibitor, when compared to before the treatment. The gene discussed is BRAF; the disease is melanoma.